Core Viewpoint - Haipai Ke, a maternal and infant vertical e-commerce platform, has submitted an IPO application to the Hong Kong Stock Exchange despite experiencing significant financial losses over the past two years, with a net profit decline of 2991.35% in 2023 and a further drop of 50.4% in 2024 [1][2] Financial Performance - Haipai Ke's revenue for 2022, 2023, and 2024 was 895 million yuan, 1.067 billion yuan, and 1.032 billion yuan, respectively, showing a year-on-year growth of 19.16% in 2023 followed by a decline of 3.22% in 2024 [1] - The net profit attributable to shareholders was 2 million yuan in 2022, -52 million yuan in 2023, and -78 million yuan in 2024, indicating a drastic drop in profitability [1] - In 2023, the company reported a revenue of 1.067 billion yuan with a sales cost of 665 million yuan, resulting in a gross profit of only 401 million yuan [2] Business Model and Market Position - Haipai Ke operates as a multi-functional platform connecting supply and demand for family care and nutrition products in China's lower-tier markets, achieving a transaction volume of 8.6 billion yuan in 2024 [3] - The platform has a market share of 10.1% in the family care and nutrition product sector, connecting approximately 4,200 registered sellers and covering over 290,000 registered buyers across 31 provinces and regions [3] - The company has shifted towards a self-operated business model, focusing on high-demand products such as infant formula and dietary supplements, with self-operated business revenue reaching 802 million yuan in 2024, accounting for 77.7% of total revenue [5] Funding and Debt Situation - Haipai Ke has undergone multiple funding rounds, raising significant capital from various investors, including over 337.2 million USD in A round and 128 million USD in C round [7][8] - The company faces a substantial debt burden, with net liabilities recorded at 1.733 billion yuan, 1.917 billion yuan, and 2.001 billion yuan for the years ending December 31, 2022, 2023, and 2024, respectively [11] - The financial strain is exacerbated by the need to repurchase preferred shares from investors, leading to liquidity risks and potential limitations on operational funding and expansion plans [11]